BostonGene-Integrated Genomic Registry (BIGR)

Recruiting now

Conditions studied: Malignancy

In brief

The purpose of this project is to develop a comprehensive database of genomic, transcriptomic, molecular, and clinical characteristics of oncology patients to discover, define, and develop genomic and transcriptomic markers to improve future clinical outcomes across cancer types

Key facts

Study ID

NCT04991922

Run by

BostonGene

People needed

100000

Starts

2021-07-01

Expected to finish

2036-07-01

Last updated by the study team

2024-02-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Suspected or confirmed malignancy
• Planned comprehensive genomic (> 100 genes) and/or molecular analysis; or genomic and/or molecular data available from prior sequencing
• Baseline demographics and treatment information available
• Willingness for future contact by BIRG study personnel to provide information regarding associated cancer outcomes and treatment.
• Signed informed consent to participate in the study.
• Living in the United States at the time of enrollment

You may not qualify if…

• Life expectancy < 3 months

Where it is running

• BostonGene — Waltham, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.